Send Message
Home News

company news about WHO Launches Global Infectious Disease Surveillance Network

China Hangzhou AllTest Biotech CO.,LTD certification
Customer Reviews
We recently started selling your HCG tests via our Australian partner and have been very impressed with the quality and consistency of the tests. They seem to be superior to our current manufacturer and we also know that you are far more reliable in terms of production times and communication.

—— One customer from Europe

We would like to explore the possibility of switching our HCG tests over to you. We have been reluctant in the past to move everything over to you as it makes us very reliant on you. However, we have always found you to be by far the most reliable of all our Chinese manufacturers and so we feel comfortable strengthening our partnership further

—— One customer from Europe

I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

I'm Online Chat Now
Company News
WHO Launches Global Infectious Disease Surveillance Network
Latest company news about WHO Launches Global Infectious Disease Surveillance Network

The World Health Organization (WHO) has launched a global network called the International Pathogen Surveillance Network (IPSN) in collaboration with partners to protect people from the threat of infectious diseases. The IPSN is a platform connecting countries and regions to enhance systems for sample collection, analysis, public health data-driven decision-making and broad information sharing. The network aims to make pathogen genome sequencing and analysis available to every country as part of its public health system, with the ultimate goal of identifying and responding to disease threats before they escalate into epidemics or pandemics.


Pathogen genomics involves studying the genetic code of viruses, bacteria and other disease-causing organisms to gain insight into their infectiousness, lethality and modes of transmission. This information can help scientists and public health officials identify and monitor diseases, prevent and respond to outbreaks, and facilitate the development of effective treatments and vaccines.


The ongoing COVID-19 pandemic highlights the critical role of pathogen genomics in responding to global health crises. Rapid sequencing of the SARS-CoV-2 genome has played a key role in the development and timely deployment of an effective vaccine, as well as in identifying new, more infectious variants of the virus. Genomic analysis is central to epidemic and pandemic preparedness and response, and extends to surveillance of a wide range of diseases such as foodborne illness, influenza, tuberculosis, and HIV.


Despite advances in genomics capacity during pandemics, many countries still lack effective systems for sample collection, analysis,and data utilization in public health decision-making. Inadequate sharing of data, practices, and innovations hinders the establishment of a robust global health surveillance architecture. Additionally, budget cuts are facing significant cuts, even in high-income countries, which could hinder progress in public health surveillance and response efforts.


IPSN brings together leading experts in genomics and data analysis from various sectors, including governments, philanthropic foundations, multilateral organizations, civil society, academia, and the private sector. This collaborative effort aims to optimize routine disease surveillance activities and respond to disease threats before they escalate into epidemics or pandemics.


In conclusion, the International Pathogen Surveillance Network is a critical step towards improving global health surveillance and response efforts. By harnessing the power of pathogen genomics and facilitating global collaboration, IPSN aims to prevent and respond to disease threats before they become epidemics or pandemics, thus protecting people worldwide from the threat of infectious diseases.




Reference Link:

Pub Time : 2023-05-29 15:21:07 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: 86-13989889852

Send your inquiry directly to us (0 / 3000)